GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $392,073 (100.0% shares, 0.0% debt)

Holdings (35)

VNDA VANDA PHARMACEUTICALS INC. CMN 11.5%
Value ($000) $45,030 Shares 2,706,134 Est. Cost $10.50 Unrealized +28.3%
ADAMAS PHARMACEUTICALS INC CMN 10.9%
Value ($000) $42,688 Shares 2,601,351 Est. Cost $18.31 Unrealized
SYNERGY PHARMACEUTICALS INC CMN 9.0%
Value ($000) $35,386 Shares 6,422,232 Est. Cost $4.49 Unrealized
ZOGENIX INC CMN 7.1%
Value ($000) $27,900 Shares 2,440,959 Est. Cost $11.56 Unrealized
FOAMIX PHARMACEUTICALS LIMITED CMN 6.5%
Value ($000) $25,645 Shares 2,769,425 Est. Cost $8.97 Unrealized
DERMIRA INC CMN 5.9%
Value ($000) $22,977 Shares 679,403 Est. Cost $29.25 Unrealized
IGNYTA INC CMN 5.6%
Value ($000) $21,859 Shares 3,475,227 Est. Cost $5.59 Unrealized
ENTA ENANTA PHARMACEUTICALS INC CMN 5.4%
Value ($000) $21,022 Shares 790,000 Est. Cost $25.23 Unrealized -8.0%
NBIX NEUROCRINE BIOSCIENCES INC CMN 5.1%
Value ($000) $19,956 Shares 394,080 Est. Cost $41.64 Unrealized +19.6%
AVEXIS INC CMN 4.0%
Value ($000) $15,703 Shares 381,095 Est. Cost $41.20 Unrealized
MERRIMACK PHARMACEUTICALS INC CMN 4.0%
Value ($000) $15,508 Shares 2,442,159 Est. Cost $6.35 Unrealized
COLUCID PHARMACEUTICALS INC CMN 3.9%
Value ($000) $15,260 Shares 400,000 Est. Cost $38.15 Unrealized
BOVIE MEDICAL CORPORATION CMN 3.6%
Value ($000) $13,963 Shares 2,680,000 Est. Cost $2.72 Unrealized
SAGE THERAPEUTICS, INC CMN 3.1%
Value ($000) $12,198 Shares 264,893 Est. Cost $30.13 Unrealized
CONNECTURE INC 2.0%
Value ($000) $7,759 Shares 4,127,232 Est. Cost $9.01 Unrealized
ARADIGM CORP CMN 1.8%
Value ($000) $6,900 Shares 1,002,962 Est. Cost $8.85 Unrealized
OCERA THERAPEUTICS INC CMN CLASS 1.3%
Value ($000) $5,184 Shares 1,963,777 Est. Cost $6.20 Unrealized
DBV TECHNOLOGIES SA SPONSORED ADR CMN 1.2%
Value ($000) $4,776 Shares 131,452 Est. Cost $36.33 Unrealized
SUNESIS PHARMACEUTICALS INC CMN 1.2%
Value ($000) $4,648 Shares 1,063,573 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES CMN 1.0%
Value ($000) $3,931 Shares 2,637,969 Est. Cost $1.49 Unrealized
BCRX PUT/BCRX @ 5 EXP 03/17/2017 0.8%
Value ($000) $3,197 Shares 725,000 Est. Cost Unrealized
PUT/GWPH @ 95 EXP 10/21/2016 0.8%
Value ($000) $3,159 Shares 23,800 Est. Cost Unrealized
DIPEXIUM PHARMACEUTICALS INC CMN 0.7%
Value ($000) $2,594 Shares 178,930 Est. Cost $12.24 Unrealized
TENAX THERAPEUTICS INC CMN 0.7%
Value ($000) $2,568 Shares 1,108,593 Est. Cost $3.93 Unrealized
PDL BIOPHARMA INC CMN 0.6%
Value ($000) $2,161 Shares 645,000 Est. Cost $3.35 Unrealized
TETRAPHASE PHARMACEUTICALS INC CMN 0.4%
Value ($000) $1,733 Shares 452,375 Est. Cost $6.71 Unrealized
CATABASIS PHARMACEUTICALS, INC CMN 0.4%
Value ($000) $1,540 Shares 250,000 Est. Cost $6.16 Unrealized
MIRATI THERAPEUTICS INC CMN 0.4%
Value ($000) $1,505 Shares 227,657 Est. Cost $6.61 Unrealized
SERES THERAPEUTICS, INC. CMN 0.4%
Value ($000) $1,475 Shares 120,000 Est. Cost $12.29 Unrealized
PUT/MCRB @ 20 EXP 10/21/2016 0.4%
Value ($000) $1,475 Shares 120,000 Est. Cost $12.29 Unrealized
INOTEK PHARMACEUTICALS CORP CMN 0.2%
Value ($000) $892 Shares 94,077 Est. Cost $9.48 Unrealized
CALL/NVAX @ 8 EXP 10/21/2016 0.2%
Value ($000) $851 Shares 409,200 Est. Cost Unrealized
STREAMLINE HEALTH SOLUTNS, INC CMN 0.1%
Value ($000) $279 Shares 151,611 Est. Cost $6.45 Unrealized
ARDX ARDELYX INC CMN 0.0%
Value ($000) $194 Shares 15,000 Est. Cost $9.95 Unrealized +5.3%
CALL/OPHT @ 80 EXP 01/20/2017 0.0%
Value ($000) $157 Shares 3,400 Est. Cost Unrealized